Galderma Investigational Site # 7051 — New York, New York

Galderma Investigational Site # 7051 is a clinical research site located in New York, New York, United States 10023.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Galderma Investigational Site # 7051 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prurigo Nodularis.

Sponsors: Galderma R&D.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Galderma Investigational Site # 7051?

Galderma Investigational Site # 7051 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Galderma Investigational Site # 7051 conducted?

Galderma Investigational Site # 7051 has 1 clinical trials on record, with 1 currently active. Their work covers Prurigo Nodularis.

Is Galderma Investigational Site # 7051 accredited by Crixeo Health?

Galderma Investigational Site # 7051 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Galderma Investigational Site # 7051?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.